American Journal of Bioethics 11 (12):21-25 (2011)
|Abstract||When prostate-specific antigen (PSA) testing was introduced, proponents expected it to cut prostate-cancer mortality and did not expect it to unleash an epidemic of unnecessary treatments. Now that evidence of a mortality benefit remains unclear while evidence of overtreatment in undeniable, there is understandable interest in reducing the human costs of the PSA system. Two related drugs, finasteride and dutasteride, both proven to reduce the incidence of prostate cancer and the ?risk of diagnosis,? are being promoted accordingly. However, if not for the flaws of the PSA system the use of these drugs for purposes of prevention would lose its rationale. Not only are the drugs in this sense dependent on a faulty system, but their own mortality benefits are as speculative as PSA's?in addition to which, they introduce new risks.|
|Keywords||No keywords specified (fix it)|
|Through your library||Configure|
Similar books and articles
Stewart Justman (2012). Uninformed Consent: Mass Screening for Prostate Cancer. Bioethics 26 (3):143-148.
Stewart Justman (2011). Forfeited Health: Response to Open Peer Commentaries on “What's Wrong With Chemoprevention of Prostate Cancer?”. American Journal of Bioethics 11 (12):W1-W2.
Mary McNaughton Collins, Floyd J. Fowler, Richard G. Roberts, Joseph E. Oesterling, George J. Annas & Michael J. Barry (1997). Medical Malpractice Implications of PSA Testing for Early Detection of Prostate Cancer. Journal of Law, Medicine and Ethics 25 (4):234-242.
Caroline J. Huang & Matthew L. Baum (2011). A Rational Basis for Chemoprevention of Prostate Cancer. American Journal of Bioethics 11 (12):27-29.
Ronald Ennis & Alan Jotkowitz (2011). Good Ethics Begins With Sound Medicine: Prostate Cancer Screening and Chemoprevention. American Journal of Bioethics 11 (12):26-27.
Susan Gilbert (2010). Personalized Cancer Care in an Age of Anxiety. Hastings Center Report 40 (5):18-21.
P. Vineis & R. Satolli (forthcoming). From Figures to Values: The Implicit Ethical Judgements in Our Measures of Health. Public Health Ethics 5 (1):22-28.
Howard L. Parnes (2011). Prostate Cancer Prevention: Do the 5-ARIs Make the Grade? American Journal of Bioethics 11 (12):30-31.
Rebecca Dresser (2011). Bioethics and Cancer: When the Professional Becomes Personal. Hastings Center Report 41 (6):14-18.
Michael J. Barry, Pamela H. Wescott, Ellen J. Reifler, Yuchaio Chang & Benjamin W. Moulton (2008). Reactions of Potential Jurors to a Hypothetical Malpractice Suit Alleging Failure to Perform a Prostate-Specific Antigen Test. Journal of Law, Medicine and Ethics 36 (2):396-402.
Aaron Wilson (2013). Justice and Lung Cancer. Journal of Medicine and Philosophy 38 (2):219-234.
Neil I. Wiener & David L. Wiesenthal (1999). Ethical Questions in the Age of the New Eugenics. Science and Engineering Ethics 5 (3):383-394.
Added to index2011-12-07
Total downloads5 ( #161,910 of 556,837 )
Recent downloads (6 months)0
How can I increase my downloads?